[68 Ga]Ga-PSMA-11 in diagnosis and follow-up after transarterial chemoembolization in hepatocellular carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
[68 Ga]Ga-PSMA-11 in diagnosis and follow-up after transarterial chemoembolization in hepatocellular carcinoma ; day:5 ; month:8 ; year:2023 ; pages:1-2
European journal of nuclear medicine and molecular imaging ; (5.8.2023), 1-2
- Creator
-
Kunikowska, Jolanta
Korzeniowski, Krzysztof
Pełka, Kacper
Lamparski, Krzysztof
Patkowski, Waldemar
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-023-06372-4
- URN
-
urn:nbn:de:101:1-2023110111085678663645
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kunikowska, Jolanta
- Korzeniowski, Krzysztof
- Pełka, Kacper
- Lamparski, Krzysztof
- Patkowski, Waldemar
- SpringerLink (Online service)
Other Objects (12)
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT
Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT
Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma
Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma
PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
Dynamic CT angiography for therapy evaluation after transarterial chemoembolization of hepatocellular carcinoma
Ischemic Duodenal Ulceration after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT
Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT
Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma
Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma
PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
Dynamic CT angiography for therapy evaluation after transarterial chemoembolization of hepatocellular carcinoma
Ischemic Duodenal Ulceration after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT
Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT
Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma
Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma
PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
Dynamic CT angiography for therapy evaluation after transarterial chemoembolization of hepatocellular carcinoma